Friday, May 24, 2024
Advertisement

Increase in patients and complexity boosts King Edward VII

King Edward VII Sister Agnes Hospital in central London has reported EBITDA of £352,000 for the year ended 31 March 2017 – its best...
sk:n plans to continue growth strategy under ownership of TriSpan

Cosmetic surgery market buoyant for MYA

The cosmetic surgery market was buoyant in 2017, according to Harrogate-based provider MYA Cosmetic Surgery. The company reported an 14% jump in turnover to £21.5m...

Medicash expecting continued growth in new business despite Covid

Health cash plan provider Medicash Health Benefits Limited said it expects to win new business and maintain low administration expense ratios in 2020 despite...

Trustedoctor merges with critical illness provider Further Group

Digital health and virtual consultation platform Trustedoctor has merged with global critical illness and protection provider Further Group.  Financial details of the transaction have not...

Expansion boosts income at Vita Health Group

Physiotherapy and mental health specialist Vita Health Group has reported a 38% jump in turnover to £26.1m on the back of continued organic growth...

Covid closures impact earnings at Portman Healthcare

UK dental group Portman Healthcare has reported a small increase in turnover for 2020 but said EBITDA was impacted by practice closures and interruption to acquisitions...

M&G launches new fund focused on health improvement

M&G Investments has launched a new fund specifically for companies in the health and social care sectors which seek to promote better health and...

Earnings improve at London Women’s Clinic

Fertility services provider The London Women’s Clinic has reported a 32% jump in EBITDA for the year to 31 October 2020 despite reduced revenue. Turnover...
Sensyne Health CEO Paul Drayson

Sensyne appoints banks to consider potential MBO

Clinical AI company Sensyne Health has begun a formal sale process after founder and CEO Lord Paul Drayson put forward proposals for a management...

Covid-19 disruption reverses growth at Genesis Cancer Care

Australian-owned cancer treatment network Genesis Cancer Care has announced operating losses of £5.5m for the year ended 30 June 2021 following a ‘challenging year’ which saw...